| abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLUTION INCLUDING: A) PLECONARIL; B) A SOLVENT THAT INCLUDES A TRIGLYCERIDE PREPARED FROM A MIXTURE OF SATURATED FATTY ACIDS SUCH AS: i) CAPRIC ACID IN AN AMOUNT OF 30% TO 40% BY WEIGHT, ii) CAPRILIC ACID IN AN AMOUNT OF 50% TO 65% BY WEIGHT , AND iii) FATTY ACIDS WITH A CHAIN LENGTH OF C6, C12 AND C14 IN A QUANTITY OF 5%; C) A CORTICOSTEROID SUCH AS MOMETASONE FUROATE, DEXAMETASONE, BUDESONIDE, AMONG OTHERS; D) A DECONGESTIVE SUCH AS OXIMETAZOLINA, PSEUDOEPEDRINA, NAFAZOLINA, AMONG OTHERS; E) AN AQUEOUS CARRIER THAT INCLUDES MICROCRYSTALLINE CELLULOSE AND ALKALINE METAL CARBOXIALKYL CELLULOSE; AND F) ANOTHER ACTIVE AGENT SUCH AS AN ANTIHISTAMINIC, AN ANTI-INFLAMMATORY, AN EXPECTORANT, AMONG OTHERS. SAID COMPOSITION IS AN AEROSOL FOR INHALATION BEING USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES |